RUA Life Sciences (LON:RUA) Stock Price Down 1.4% – Time to Sell?

RUA Life Sciences plc (LON:RUA)’s share price was down 1.4% during trading on Wednesday . The stock traded as low as GBX 11.63 ($0.15) and last traded at GBX 12.08 ($0.16). Approximately 208,450 shares traded hands during mid-day trading, an increase of 17% from the average daily volume of 177,495 shares. The stock had previously closed at GBX 12.25 ($0.16).

RUA Life Sciences Stock Performance

The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42. The stock has a market capitalization of £7.49 million, a PE ratio of -2.81 and a beta of 1.21. The firm’s fifty day moving average is GBX 12.61 and its 200-day moving average is GBX 12.11.

Insider Transactions at RUA Life Sciences

In other RUA Life Sciences news, insider William D. Brown bought 25,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The stock was purchased at an average price of GBX 13 ($0.17) per share, for a total transaction of £3,250 ($4,227.92). Corporate insiders own 51.33% of the company’s stock.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.